Antidepressant-like Effects Induced by Chronic Blockade of the Purinergic 2X7 Receptor through Inhibition of Non-like Receptor Protein 1 Inflammasome in Chronic Unpredictable Mild Stress Model of Depression in Rats

키워드

참고문헌 (69)

1. Kessler RC, "The costs of depression", Psychiatr Clin North Am, 35, pp.1~14 (2012)
2. Menken M, "The global burden of disease study : implications for neurology", Arch Neurol, 57, pp.418~420 (2000)
3. Murray CJ, "Alternative projections of mortality and disability by cause 1990-2020 : global burden of disease study", Lancet, 349, pp.1498~1504 (1997)
4. Culpepper L, "Why do you need to move beyond first-line therapy for major depression", J Clin Psychiatry, 71(Suppl 1), pp.4~9 (2010)
5. Sahin C, "The neuroinflammation perspective of depression : reuniting the outstanding mechanisms of the pathophysiology", Klin Psikofarmakol Bülteni Bull Clin Psychopharmacol, 26, pp.196~206 (2016)
6. Pamela Ferrari, "Depression and Mania Induce Pro-inflammatory Activation of Macrophages Following Application of Serum from Individuals with Bipolar Disorder", Clinical Psychopharmacology and Neuroscience, 16(1), pp.103~108 (2018), 대한정신약물학회[DOI]
7. Réus GZ, "The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders", Neuroscience, 300, pp.141~154 (2015)
8. Izabela G. Barbosa, "Plasma Levels of Tumor Necrosis Factor Superfamily Molecules Are Increased in Bipolar Disorder", Clinical Psychopharmacology and Neuroscience, 15(3), pp.269~275 (2017), 대한정신약물학회[DOI]
9. Miller AH, "Inflammation and its discontents : the role of cytokines in the pathophysiology of major depression", Biol Psychiatry, 65, pp.732~741 (2009)
10. Miller AH, "The role of inflammation in depression : from evolutionary imperative to modern treatment target", Nat Rev Immunol, 16, pp.22~34 (2016)
11. Strawbridge R, "Inflammation and clinical response to treatment in depression : a meta-analysis", Eur Neuropsychopharmacol, 25, pp.1532~1543 (2015)
12. Olivia May Dean, "Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial", Clinical Psychopharmacology and Neuroscience, 12(3), pp.180~188 (2014), 대한정신약물학회
13. Raison CL, "A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression : the role of baseline inflammatory biomarkers", JAMA Psychiatry, 70, pp.31~41 (2013)
14. Iwata M, "The inflammasome : pathways linking psychological stress, depression, and systemic illnesses", Brain Behav Immun, 31, pp.105~114 (2013)
15. Wei L, "BDNF", TrkB pathway mediates the antidepressant-like role of H2S in CUMS-exposed rats by inhibition of hippocampal ER stress, 2018, pp.20, 252~261
16. Song MT, "Astragaloside IV ameliorates neuroinflammation-induced depressive-like behaviors in mice via the PPARγ", NF-B, Acta Pharmacol Sin, pp.2018, 39[DOI]
17. Song Y, "Perilla aldehyde attenuates CUMS-induced depressive-like behaviors via regulating TXNIP", TRX, Life Sci, pp.2018, 206[DOI]
18. Kaufmann FN, "NLRP3 inflammasome-driven pathways in depression : clinical and preclinical findings", Brain Behav Immun, 64, pp.367~383 (2017)
19. Haapakoski R, "Innate and adaptive immunity in the development of depression : an update on current knowledge and technological advances", Prog Neuropsychopharmacol Biol Psychiatry, 66, pp.63~72 (2016)
20. Velasquez S, "Inflammasome activation in major depressive disorder : a pivotal linkage between psychological stress, purinergic signaling, and the kynurenine pathway", Biol Psychiatry, 80, pp.4~5 (2016)
21. Kummer JA, "Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response", J Histochem Cytochem, 55, pp.443~452 (2007)
22. Kigerl KA, "Pattern recognition receptors and central nervous system repair", Exp Neurol, 258, pp.5~16 (2014)
23. de Rivero Vaccari JP, "Activation and regulation of cellular inflammasomes : gaps in our knowledge for central nervous system injury", J Cereb Blood Flow Metab, 34, pp.369~375 (2014)
24. Di Virgilio F, "The therapeutic potential of modifying inflammasomes and NOD-like receptors", Pharmacol Rev, 65, pp.872~905 (2013)
25. Guarda G, "Regulation of inflammasome activity", Immunology, 130, pp.329~336 (2010)
26. Iwata M, "Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor", Biol Psychiatry, 80, pp.12~22 (2016)
27. Fleshner M, "Danger signals and inflammasomes : stress-evoked sterile inflammation in mood disorders", Neuropsychopharmacology, 42, pp.36~45 (2017)
28. Zhang Y, "NLRP3 inflammasome mediates chronic mild stress-induced depression in mice via neuroinflammation", Int J Neuropsychopharmacol, 18, pp.pyv006~ (2015)
29. Liu B, "Icariin exerts an antidepressant effect in an unpredictable chronic mild stress model of depression in rats and is associated with the regulation of hippocampal neuroinflammation", Neuroscience, 294, pp.193~205 (2015)
30. Alcocer-Gómez E, "Stress-induced depressive behaviors require a functional NLRP3 inflammasome", Mol Neurobiol, 53, pp.4874~4882 (2016)
31. Freeman LC, "The pathogenic role of the inflammasome in neurodegenerative diseases", J Neurochem, 136(Suppl 1), pp.29~38 (2016)
32. Halmai Z, "Associations between depression severity and purinergic receptor P2RX7 gene polymorphisms", J Affect Disord, 150, pp.104~109 (2013)
33. Hejjas K, "Association between depression and the Gln460Arg polymorphism of P2RX7 gene: a dimensional approach", Am J Med Genet B Neuropsychiatr Genet, 150B, pp.295~299 (2009)
34. Nagy G, "P2RX7 Gln460Arg polymorphism is associated with depression among diabetic patients", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.1884~1888 (2008)
35. Soronen P, "P2RX7 gene is associated consistently with mood disorders and predicts clinical outcome in three clinical cohorts", Am J Med Genet B Neuropsychiatr Genet, 156B, pp.435~447 (2011)
36. Basso AM, "Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety : relevance for neuropsychiatric disorders", Behav Brain Res, 198, pp.83~90 (2009)
37. Wilkinson SM, "The first CNS-active carborane : a novel P2X7 receptor antagonist with antidepressant activity", ACS Chem Neurosci, 5, pp.335~339 (2014)
38. Jiang LH, "Brilliant blue G selectively blocks ATP-gated rat P2X(7)receptors", Mol Pharmacol, 58, pp.82~88 (2000)
39. Min Ma, "Effects of Brilliant Blue G on Serum Tumor Necrosis Factor-α Levels and Depression-like Behavior in Mice after Lipopolysaccharide Administration", Clinical Psychopharmacology and Neuroscience, 12(1), pp.31~36 (2014), 대한정신약물학회
40. Czéh B, "Animal models of major depression and their clinical implications", Prog Neuropsychopharmacol Biol Psychiatry, 64, pp.293~310 (2016)
41. Willner P, "Chronic mild stress(CMS)revisited : consistency and behavioural-neurobiological concordance in the effects of CMS", Neuropsychobiology, 52, pp.90~110 (2005)
42. Willner P, "Chronic mild stress-induced anhedonia : a realistic animal model of depression", Neurosci Biobehav Rev, 16, pp.525~534 (1992)
43. Abelaira HM, "Animal models as tools to study the pathophysiology of depression", Rev Bras Psiquiatr, 35(Suppl 2), pp.S112~S120 (2013)
44. Deussing JM, "Animal models of depression", Drug Discov Today Dis Models, 3, pp.375~383 (2006)
45. Wiborg O, "Chronic mild stress for modeling anhedonia", Cell Tissue Res, 354, pp.155~169 (2013)
46. Yang C, "Quantitative proteomic study of the plasma reveals acute phase response and LXR", RXR and FXR, Mol Med Rep, pp.2018, 17[DOI]
47. Liu W, "Swimming exercise reverses CUMS-induced changes in depression-like behaviors and hippocampal plasticity-related proteins", J Affect Disord, 227, pp.126~135 (2018)
48. Csölle C, "Neurochemical changes in the mouse hippocampus underlying the antidepressant effect of genetic deletion of P2X7 receptors", PLoS One, 8, pp.e66547~ (2013)
49. Porsolt RD, "Depression : a new animal model sensitive to antidepressant treatments", Nature, 266, pp.730~732 (1977)
50. Willner P, "Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation", sychopharmacology (Berl), 134, pp.319~329 (1997)
51. Lu M, "Iptakalim confers an antidepressant effect in a chronic mild stress model of depression through regulating neuro-inflammation and neurogenesis", Int J Neuropsychopharmacol, 17, pp.1501~1510 (2014)
52. Pereira VS, "Antidepressant-and anticompulsivelike effects of purinergic receptor blockade : involvement of nitric oxide", Eur Neuropsychopharmacol, 23, pp.1769~1778 (2013)
53. Pan Y, "Microglial NLRP3 inflammasome activation mediates IL-1-related inflammation in prefrontal cortex of depressive rats", Brain Behav Immun, 41, pp.90~100 (2014)
54. Lu K, "Brilliant blue G attenuates lipopolysaccharide-mediated microglial activation and inflammation", Neural Regen Res, 8, pp.599~608 (2013)
55. Wang YC, "Neuroprotective effects of brilliant blue G on the brain following traumatic brain injury in rats", Mol Med Rep, 12, pp.2149~2154 (2015)
56. Alcocer-Gómez E, "NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder", Brain Behav Immun, 36, pp.111~117 (2014)
57. Xu Y, "NLRP3 inflammasome activation mediates estrogen deficiency-induced depression-and anxiety-like behavior and hippocampal inflammation in mice", Brain Behav Immun, 56, pp.175~186 (2016)
58. Xue J, "L-Menthone confers antidepressant-like effects in an unpredictable chronic mild stress mouse model via NLRP3 inflammasome-mediated inflammatory cytokines and central neurotransmitters", Pharmacol Biochem Behav, 134, pp.42~48 (2015)
59. Zhang ZT, "Activation of the NLRP3 inflammasome in lipopolysaccharide-induced mouse fatigue and its relevance to chronic fatigue syndrome", J Neuroinflammation, 13, pp.71~ (2016)
60. Li R, "Apigenin ameliorates chronic mild stress-induced depressive behavior by inhibiting interleukin-1 production and NLRP3 inflammasome activation in the rat brain", Behav Brain Res, 296, pp.318~325 (2016)
61. Zhang Y, "Involvement of inflammasome activation in lipopolysaccharide-induced mice depressive-like behaviors", CNS Neurosci Ther, 20, pp.119~124 (2014)
62. Sahin C, "Agmatine reverses sub-chronic stress induced nod-like receptor protein 3(NLRP3)activation and cytokine response in rats", Basic Clin Pharmacol Toxicol, 119, pp.367~375 (2016)
63. Sahin C, "Future directions of cytokine hypothesis in depression : ‘NLRP3 inflamazomu’", Klin Psikofarmakol Bülteni Bull Clinical Psychopharmacol, 23, pp.280~288 (2013)
64. Wang Y, "TLR4-NF-B signal involved in depressive-like behaviors and cytokine expression of frontal cortex and hippocampus in stressed C57BL", 6 and ob, Neural Plast, pp.2018, 2018[DOI]
65. Peng WF, "Different behavioral and pathological changes between epilepsy-associated depression and primary depression models", Epilepsy Behav, 83, pp.212~218 (2018)
66. Wang YL, "Microglial activation mediates chronic mild stress-induced depressive-and anxiety-like behavior in adult rats", J Neuroinflammation, 15, pp.21~ (2018)
67. Kimbler DE, "Activation of P2X7 promotes cerebral edema and neurological injury after traumatic brain injury in mice", PLoS One, 7, pp.e41229~ (2012)
68. Peng W, "Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury", Proc Natl Acad Sci U S A, 106, pp.12489~12493 (2009)
69. Fehlings MG, "Immunoglobulin G: a potential treatment to attenuate neuroinflammation following spinal cord injury", J Clin Immunol, 30(Suppl 1), pp.S109~S112 (2010)

관련 논문AI추천